Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Harefuah|June 30, 2006
[Trends in management, morbidity and mortality of patients with acute myocardial infarction hospitalized in the last decade]Hanoch Hod, Shmuel Gotlieb, Manfred Green, et al.
Journal of Cardiovascular Electrophysiology|March 10, 2000
Are routine arrhythmia inductions necessary in patients with pectoral implantable cardioverter defibrillators?M Glikson, D Luria, P A Friedman, et al.
Archives of Internal Medicine|April 12, 2006
Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrateAlexander Tenenbaum, Enrique Z Fisman, Valentina Boyko, et al.
International Journal of Cardiology|March 1, 2006
CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart diseaseDavid Tanne, Moti Haim, Uri Goldbourt, et al.
The American Journal of Cardiology|June 21, 2006
Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarctionEnrique Z Fisman, Michal Benderly, Ricardo J Esper, et al.
Journal of Cardiovascular Risk|June 1, 1995
Asymptomatic hyperglycemia in coronary heart disease: frequency and associated lipid and lipoprotein levels in the bezafibrate infarction prevention (BIP) register. The BIP Study GroupS Behar, V Boyko, M Benderly, et al.
Frontiers in Cardiovascular Medicine|November 17, 2022
Sex related differences in the characteristics and outcomes of heart failure: A sub analysis of heart failure disease management studyAvishay Grupper, Dov Freimark, Havi Murad, et al.
The American Journal of Cardiology|April 3, 2007
Safety and efficacy of the FilterWire EZ in acute ST-segment elevation myocardial infarctionVictor Guetta, Morris Mosseri, Michael Shechter, et al.
Pediatric Research|March 1, 1989
Defective leukocyte fungicidal activity in end-organ resistance to 1,25-dihydroxyvitamin DA Etzioni, Z Hochberg, S Pollak, et al.
The American Journal of Medicine|November 3, 2001
A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention studyD Tanne, M Benderly, U Goldbourt, et al.
Pageof 12